Literature DB >> 21551464

Two concepts of therapeutic optimism.

Lynn A Jansen1.   

Abstract

Researchers and ethicists have long been concerned about the expectations for direct medical benefit expressed by participants in early phase clinical trials. Early work on the issue considered the possibility that participants misunderstand the purpose of clinical research or that they are misinformed about the prospects for medical benefit from these trials. Recently, however, attention has turned to the possibility that research participants are simply expressing optimism or hope about their participation in these trials. The ethical significance of this therapeutic optimism remains unclear. This paper argues that there are two distinct phenomena that can be associated with the term 'therapeutic optimism'-one is ethically benign and the other is potentially worrisome. Distinguishing these two phenomena is crucial for understanding the nature and ethical significance of therapeutic optimism. The failure to draw a distinction between these phenomena also helps to explain why different writers on the topic often speak past one another.

Entities:  

Mesh:

Year:  2011        PMID: 21551464      PMCID: PMC3159718          DOI: 10.1136/jme.2010.038943

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  12 in total

1.  Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism.

Authors:  Sam Horng; Christine Grady
Journal:  IRB       Date:  2003 Jan-Feb

Review 2.  Optimistic biases about personal risks.

Authors:  N D Weinstein
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

3.  The problem with optimism in clinical trials.

Authors:  Lynn A Jansen
Journal:  IRB       Date:  2006 Jul-Aug

4.  Hope and exploitation.

Authors:  Adrienne M Martin
Journal:  Hastings Cent Rep       Date:  2008 Sep-Oct       Impact factor: 2.683

5.  The dark side of optimism: unrealistic optimism about problems with alcohol predicts subsequent negative event experiences.

Authors:  Amanda J Dillard; Amanda M Midboe; William M P Klein
Journal:  Pers Soc Psychol Bull       Date:  2009-08-31

6.  Unrealistic optimism about susceptibility to health problems.

Authors:  N D Weinstein
Journal:  J Behav Med       Date:  1982-12

7.  'I'm less at risk than most guys': gay men's unrealistic optimism about becoming infected with HIV.

Authors:  R S Gold; H M Aucote
Journal:  Int J STD AIDS       Date:  2003-01       Impact factor: 1.359

8.  Optimistic bias in the perception of personal risk: patterns in schizophrenia.

Authors:  Kristen J Prentice; James M Gold; William T Carpenter
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

9.  Effect of unrealistic optimism, perceived control over disease, and experience with female cancer on behavioral intentions of Israeli women to undergo screening tests.

Authors:  Sivia Barnoy; Yoram Bar-Tal; Lilit Treister
Journal:  Cancer Nurs       Date:  2003-10       Impact factor: 2.592

10.  Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent.

Authors:  Kevin P Weinfurt; Damon M Seils; Janice P Tzeng; Kate L Compton; Daniel P Sulmasy; Alan B Astrow; Nicholas A Solarino; Kevin A Schulman; Neal J Meropol
Journal:  Med Decis Making       Date:  2008-03-31       Impact factor: 2.583

View more
  22 in total

1.  Fragile X syndrome clinical trials: exploring parental decision-making.

Authors:  C S D'Amanda; H L Peay; A C Wheeler; E Turbitt; B B Biesecker
Journal:  J Intellect Disabil Res       Date:  2019-02-12

2.  Patient Preference to Accept Medical Treatment Is Associated with Spokesperson Agreement.

Authors:  Andrew J Foy; Benjamin H Levi; Lauren J Van Scoy; Ashley Bucher; Anne Dimmock; Michael J Green
Journal:  Ann Am Thorac Soc       Date:  2019-04

3.  Motivations and Decision Making Processes of Men With X-linked Retinoschisis Considering Participation in an Ocular Gene Therapy Trial.

Authors:  Amy Turriff; Delphine Blain; Morgan Similuk; Barbara Biesecker; Henry Wiley; Catherine Cukras; Paul A Sieving
Journal:  Am J Ophthalmol       Date:  2019-03-16       Impact factor: 5.258

Review 4.  Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis.

Authors:  Seward B Rutkove
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

5.  Confronting the therapeutic misconception.

Authors:  Nicole R Grieselhuber; Ira J Kodner; Douglas Brown; Jennifer Yu
Journal:  Surgery       Date:  2017-04-12       Impact factor: 3.982

Review 6.  Living laboratory: whole-genome sequencing as a learning healthcare enterprise.

Authors:  M Angrist; L Jamal
Journal:  Clin Genet       Date:  2014-09-06       Impact factor: 4.438

7.  Expectations and experiences of investigators and parents involved in a clinical trial for Duchenne/Becker muscular dystrophy.

Authors:  Holly L Peay; Aad Tibben; Tyler Fisher; Ethan Brenna; Barbara B Biesecker
Journal:  Clin Trials       Date:  2013-12-04       Impact factor: 2.486

8.  The Beneficence of Hope: Findings from a Qualitative Study with Gout and Diabetes Patients.

Authors:  Isabelle Wienand; Milenko Rakic; David Shaw; Bernice Elger
Journal:  J Bioeth Inq       Date:  2018-04-16       Impact factor: 1.352

9.  Cancer clinical trial participants' assessment of risk and benefit.

Authors:  Connie M Ulrich; Sarah J Ratcliffe; Gwenyth R Wallen; Qiuping Pearl Zhou; Kathleen Knafl; Christine Grady
Journal:  AJOB Empir Bioeth       Date:  2015-05-01

10.  Long-Term Recall of Elements of Informed Consent: A Pilot Study Comparing Traditional and Computer-Based Consenting.

Authors:  Catherine A McCarty; Richard Berg; Carol Waudby; Wendy Foth; Terrie Kitchner; Deanna Cross
Journal:  IRB       Date:  2015 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.